✦ LIBER ✦

6595 POSTER Phase I Study of Gemcitabine as a Fixed Dose Rate Infusion and S-1 Combination Therapy (FGS) in Gemcitabine-refractory Biliary Tract Cancer (BTC) Patients

✍ Scribed by Kojima, Y.; Ikeda, M.; Ueno, H.; Morizane, C.; Nakachi, K.; Mitsunaga, S.; Kondo, S.; Ohno, I.; Shimizu, S.; Okusaka, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of gemcitabine as a fix

✍ Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Shunsuke Kondo; Masafumi Ikeda; J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 226 KB

6594 Phase II study of gemcitabine as a

✍ Morizane, C.; Okusaka, T.; Ikeda, M.; Furuse, J.; Ohkawa, S.; Nakachi, K.; Suzuk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

3544 POSTER Phase I study of gemcitabine

✍ C. Morizane; T. Okusaka; J. Furuse; H. Ishii; H. Ueno; M. Ikeda; T. Ogura; K. Na 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

6596 POSTER A Randomized Phase II Study

✍ Sasaki, T.; Isayama, H.; Ito, Y.; Yasuda, I.; Toda, N.; Hanada, K.; Matsubara, S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase I dose-escalation study and popula

✍ Leijen, Suzanne; Veltkamp, Stephan A.; Huitema, Alwin D.R.; van Werkhoven, E.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 306 KB